Ftse Mib
33.747,37
0,00%
DAX
17.904,01
-0,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.676,15
-0,96%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pacific Biosciences of California Inc (PACB) Pacific Biosciences of California Inc (PACB) Notizie

Pacific Biosciences of California Inc

PACB
1,69
0,00 (0,00%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202414:05PRNUSPacBio Announces Preliminary First Quarter 2024 Revenue and..
27/3/202413:00PRNUSEstonia National Biobank Selects PacBio to Sequence 10,000..
22/3/202421:30PRNUSPacBio Grants Equity Incentive Award to New Employee
12/3/202414:05PRNUSPacBio Announces PureTarget™ Repeat Expansion Panel,..
06/3/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:32EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:22EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05PRNUSPacBio to Present at Upcoming Investor Conferences
22/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:17EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:54EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:52EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:07EDGAR2Form 8-K - Current report
15/2/202422:05PRNUSPacBio Announces Fourth Quarter and Fiscal Year 2023..
13/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202413:00PRNUSExperiential Marketing Firm VOLO Events Agency Wins Best..
12/2/202423:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202412:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202415:05PRNUSPacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96..
05/2/202412:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202422:03PRNUSPacBio to Report Fourth Quarter 2023 Financial Results on..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/1/202415:05PRNUSPacBio Announces New Nanobind PanDNA Kit Enabling HiFi..
10/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:26EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:03EDGAR2Form 8-K - Current report
08/1/202414:00PRNUSPacBio Announces Record Preliminary Fourth Quarter and Full..
27/12/202322:05PRNUSPacBio to Present at 42nd Annual J.P. Morgan Healthcare..
11/12/202314:06EDGAR2Form 8-K - Current report
11/12/202314:00PRNUSPacBio Announces the Retirement of David Botstein, Ph.D.,..
09/11/202322:10PRNUSPacBio to Present at Upcoming Investor Conferences
03/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:05PRNUSPacBio Announces HiFi Solves, a Global Consortium of..
01/11/202314:05PRNUSPacBio Enables Rare and Inherited Disease Research by Adding..
31/10/202314:05PRNUSPacBio Announces Kinnex RNA Kits, Further Scaling HiFi..
30/10/202321:06EDGAR2Form 8-K - Current report
30/10/202321:03PRNUSPacBio Announces Third Quarter 2023 Financial Results
27/10/202323:00EDGAR2Form 8-K/A - Current report: [Amend]
Apertura: Min: Max:
Chiusura: 1,69

La tua Cronologia

NASDAQ
PACB
Pacific Biosciences of C...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network